Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > From Linkedin

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Jul 22, 2024 9:12pm

97 Views

Post# 36143624

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:From Linkedin

Wow!

I watch them all. It's important to hear what all sides say so you can work out who's telling the truth and who isn't. They all tell their own version of the truth and it's "militant" minded folks like yourself who they pander to.

I hope some day you'll open your mind a bit and allow yourself to he driven by facts and information rather than ideology.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks